Drain or no drain? landmark trial settles debate after rectal cancer surgery
NCT ID NCT01269567
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether placing a temporary drain in the pelvis after rectal cancer surgery reduces the risk of serious infections like leaks or abscesses. About 500 patients were randomly assigned to receive a drain or not. The main goal was to see if drainage lowered pelvic sepsis within 30 days after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pelvic drain (a tube placed during surgery to collect fluid)
- What this could lead to
- If successful, this could confirm that routine drainage after rectal cancer surgery reduces dangerous pelvic infections, improving recovery.
- What could go wrong
- This trial is completed, but results may not apply to all patients or hospitals. Drains can cause discomfort or rare complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
494 people
The number who actually took part.
- Start date
-
Jan 2011
- Finished
-
Jan 2015
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Rectal adenocarcinoma, histopathologically proved, with or without neoadjuvant treatment * Stapler or manual infraperitoneal anastomosis * With or without stoma * With bowel preparation * Open or laparoscopic approach * Stage T1-T4 Nx Mx * Age 18 years old or older * Information of the patient and signature of informed consent * Affiliation to a regime of social insurance Exclusion Criteria: * Colonic cancer (\> 15 cm from anal verge) * Abdominoperineal resection * Associated resection (prostate, seminal bladder, vagina…) * Simultaneous liver resection * Total coloproctectomy * Emergency * Infected rectal tumour * Pregnant women, suitable to be, or current suckling * Persons deprived of freedom or under guardianship * Persons under protection of justice * Impossibility to accept the medical follow-up of the study for geographic , social or psychic reasons.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multicenter study are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHP- Saint Joseph
Paris, 75014, France
-
APHP-Kremlin Bicetre
Le Kremlin-Bicêtre, 94275, France
-
CH de BEAUVAIS
Beauvais, 60021, France
-
CHRU Lille
Lille, 59037, France
-
CHRU de Strasbourg
Strasbourg, 67000, France
-
CHU Poitiers
Poitiers, France
-
CHU d'AMIENS
Amiens, 80054, France
-
Centre Hospitalier Lyon Sud
Lyon, 69495, France
-
Département de Chirurgie Oncologique - CRLC Val d'Aurelle
Montpellier, 34298, France
-
Département de Chirurgie Oncologique - Centre Oscar Lambret
Lille, 59020, France
-
Département de Chirurgie Oncologique - Institut Paoli Calmette
Marseille, 13009, France
-
Service de Chirurgie Digestive - CHU Charles Nicolle
Rouen, 76031, France
-
Service de Chirurgie Digestive - CHU de Nantes - Hôtel Dieu
Nantes, 44093, France
-
Service de Chirurgie Digestive - Hôpital A. Michallon
La Tronche, 38700, France
-
Service de Chirurgie Digestive - Hôpital Purpan - Pavillon Dieulafoy
Toulouse, 31059, France
-
Service de Chirurgie Digestive - Hôpital Saint-André - CHU de Bordeaux
Bordeaux, 33075, France
-
Service de Chirurgie Digestive - Hôpital des Diaconnesses - La Croix Saint-Simon
Paris, 75020, France
-
Service de Chirurgie Digestive et Générale - Brabois
Vandœuvre-lès-Nancy, 54511, France
-
Service de Chirurgie Digestive et Viscérale - CHU Timone
Marseille, 13385, France
-
Service de Chirurgie Générale et Digestive - Hôpital Beaujon
Clichy, 92110, France
-
Service de Chirurgie Générale et Digestive - Hôpital Saint-Antoine
Paris, 75012, France
-
Service de Chirurgie Viscérale - CHU Pontchaillou
Rennes, 35033, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New injectable drug tested against Hard-to-Treat solid tumors
- Could a nasal tube replace a temporary ileostomy after rectal cancer surgery?
- Blood test aims to catch Cancer's return earlier
- Blood test guides immunotherapy for hidden cancer cells
- Can removing a baby tooth or widening the jaw save kids from surgery?
- Can Pre-Surgery radiation stop rectal cancer from returning?